Pfizer: FDA Accepts For Review BLA For Pentavalent Meningococcal Vaccine Candidate In Adolescents

NEW YORK CITY (dpa-AFX) - The U.S. Food and Drug Administration accepted for review a Biologics License Application or BLA for its investigational pentavalent meningococcal vaccine candidate (MenABCWY)

Related Keywords

,Pfizer ,Pfizer Inc ,Drug Administration ,More Such Health News ,Biologics License Application ,Prescription Drug User Fee Act ,Oaccepts ,Review ,Pentavalent ,Meningococcal ,Vaccine ,Candidate ,Adolescents ,